Precigen, Inc. (PGEN) Documents: SEC Filings, Investor Presentations & Press Releases

Precigen, Inc. (PGEN) documents, SEC filings and the IR site together: 93 documents, newest first; latest 2026-08-04. Read in-app with summaries. First-party data.

Documents — U.S. SEC EDGAR and the company's IR site
DateTypeDocument
2026-08-04Press releasePrecigen Reports Second Quarter 2026 Financial Results Highlighted by Accelerating PAPZIMEOS Revenue Growth
2026-08-048-KForm 8-K, Item 2.02 results
2026-08-0410-QForm 10-Q for the quarter ended Jun 30
2026-06-248-KForm 8-K, Item 5.02
2026-05-15TranscriptQ1 FY26 earnings call transcript
2026-05-13Press releasePrecigen Reports First Quarter 2026 Financial Results and Business Updates
2026-05-138-KForm 8-K, Item 2.02 results
2026-05-1310-QForm 10-Q for the quarter ended Mar 31
2026-04-30ProxyDefinitive proxy statement
2026-03-25Press releasePrecigen Reports Full Year 2025 Financial Results and Business Updates
2026-03-258-KForm 8-K, Item 2.02 results
2026-03-2510-KAnnual report on Form 10-K, FY25
2026-01-15DeckPrecigen_JPM Healthcare Conference_January 2026_vF
2025-11-13Press releasePrecigen Reports Third Quarter 2025 Financial Results and Business Updates
2025-11-138-KForm 8-K, Item 2.02 results
2025-11-1310-QForm 10-Q for the quarter ended Sep 30
2025-11-06Press releasePrecigen to Announce Third Quarter 2025 Financial Results and Provide Business Updates on November 13
2025-09-178-KForm 8-K, Item 3.02
2025-09-038-KForm 8-K, Item 1.01
TranscriptEarnings call transcript
2025-08-18DeckPAPZIMEOS Approval Call_Precigen_August 2025_FINAL
2025-08-188-KForm 8-K, Item 7.01
2025-08-188-KForm 8-K, Item 1.01
2025-08-1210-QForm 10-Q for the quarter ended Jun 30
2025-06-308-KForm 8-K, Item 5.02
2025-05-16ProxyDefinitive proxy statement
2025-05-148-KForm 8-K, Item 2.02 results
2025-05-1410-QForm 10-Q for the quarter ended Mar 31
2025-04-2810-KAnnual report on Form 10-K/A, FY24
2025-03-198-KForm 8-K, Item 2.02 results
2025-03-1910-KAnnual report on Form 10-K, FY24
2025-01-168-KForm 8-K, Item 8.01
2024-12-308-KForm 8-K, Item 1.01
2024-12-268-KForm 8-K, Item 1.01
2024-11-148-KForm 8-K, Item 2.02 results
2024-11-1410-QForm 10-Q for the quarter ended Sep 30
2024-11-078-KForm 8-K, Item 3.01
2024-10-108-KForm 8-K, Item 1.02
2024-09-238-KForm 8-K, Item 5.02
2024-08-308-KForm 8-K, Item 5.02

PGEN overview · PGEN earnings · PGEN financials · PGEN KPIs · PGEN ownership · PGEN peers

Data sourced from U.S. SEC EDGAR and the company's investor-relations site. Not personalized investment advice.